The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease)

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT01765998
• Date of registration: 06/01/2013
• Prospective Registration: Yes
• Primary sponsor: The Baruch Padeh Medical Center, Poriya
• Public title: The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease)
• Scientific title: The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) and Markers of Inflammation
• Date of first enrolment: February 2013
• Target sample size: 60
• Recruitment status: Not yet recruiting
• URL: http://clinicaltrials.gov/show/NCT01765998
• Study type: Interventional
• Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
• Phase: Phase 4

Countries of recruitment

Israel

Contacts

• Name: Arnon Blum, MD
• Affiliation: Baruch Padeh Medical Center

Key inclusion & exclusion criteria

Inclusion Criteria:

- patients with Crohns' disease who are stable or have mild acute exacerbations that
do not necessitate treatment with systemic corticosteroids

Exclusion Criteria:

- pregnant women, under 18 years or over 60 years,

- patients with known ulcerative colitis,

- patients with any cancer,

- patients with heart failure



Age minimum: 18 Years
Age maximum: 60 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Crohn's Disease

Intervention(s)

Drug: Probiotic

Drug: Placebo

Primary Outcome(s)

endothelial stem cells [Time Frame: one year]

Secondary ID(s)

18-2012.CTIL

Source(s) of Monetary Support

Please refer to primary and secondary sponsors